The number of patients in the current study is too small to determine whether elevated reactivity to CGRP and/or LGR4 definitely correlates with the development of other autoimmune diseases affecting the gastrointestinal tract or skin, but this would be an interesting study for the future. This evidence concerns the gene CALCA and autoimmune disease.